Journal of International Obstetrics and Gynecology ›› 2024, Vol. 51 ›› Issue (5): 515-518.doi: 10.12280/gjfckx.20240369

• Obstetric Physiology & Obstetric Disease: Review • Previous Articles     Next Articles

Research Progress on Low-Dose Aspirin in the Prevention of Preeclampsia

DENG Ling-ling, WU Shao-wen(), ZHANG Wei-yuan   

  1. Department of Emergency (DENG Ling-ling, WU Shao-wen), Department of Perinatal Medicine (ZHANG Wei-yuan), Beijing Obstetrics and Gynecology Hospital, Capital Medical University/Beijing Maternal and Child Health Care Hospital, Beijing 100026, China
  • Received:2024-04-22 Published:2024-10-15 Online:2024-10-17
  • Contact: WU Shao-wen, E-mail: shaowenwu0925@mail.ccmu.edu.cn

Abstract:

Aspirin prossesses anti-inflammatory, antipyretic, analgesic and antiplatelet aggregation properties. Studies have shown that taking low-dose aspirin during pregnancy can effectively reduce the incidence of preeclampsia (PE) in high-risk pregnant women, and it is now widely used in clinical practice. However, there is still no consensus on the standard for aspirin use in both domestic and international guidelines, leading to possible overextension of indications or blind use in clinical practice, which may prevent achieving the desired outcomes. Based on domestic and international guidelines and recommendations from experts and scholars, this review focuses on the applicable population, timing of administration, recommended dosage and precautions during the use of low-dose aspirin for the prevention of PE, aiming to better guide clinical practice.

Key words: Pre-eclampsia, Aspirin, Pregnancy, high-risk, Therapy, Guideline